Alchemy, a pioneering company at the forefront of healthcare accessibility, is thrilled to announce a significant funding milestone of $31 million. This investment will help us continue our mission to build and operate in-house pharmacies specifically designed for safety net clinics, with a special emphasis on STD clinics, Ryan White programs, and Federally Qualified Health Centers (FQHCs) that serve patients living with HIV and Hepatitis C. Our team, enriched by nearly two decades of experience in establishing the largest HIV access program in Africa, is committed to providing the essential physical, clinical, and digital infrastructures necessary for effective 340B pharmacy programs. With this new capital, we plan to expand our reach, allowing more clinics to access top-tier pharmacy services tailored to their unique patient populations. Our proven track record of dispensing over 25 million prescriptions nationwide illustrates our capability to substantially enhance patient care and treatment outcomes. We are excited to roll out additional clinical pharmacy programs and innovative technology solutions that will not only improve the health of vulnerable populations but also boost the financial sustainability of the pharmacies we support. This funding is not just a financial achievement; it’s a step towards a healthier future for patients in underserved communities. At Alchemy, we firmly believe that everyone deserves equitable access to quality healthcare, and we are determined to make that belief a reality. For inquiries, collaborations, or to learn more about our initiatives, please reach out to us at hello@alchemyhealth.com.












